MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cabaletta Bio (CABA) Ownership - Who owns Cabaletta Bio?

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
156
Web
https://www.cabalettabio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
489.16M
P/E Ratio
N/A
Total Cash
116.64M
Projected Growth
N/A
Total Debt
26.45M
Revenue
N/A
Risk (Beta)
3.06
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CABA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CABA
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
156
Web
https://www.cabalettabio.com